Thu. 2 May 2024, 4:27pm ET
Benzinga
Earnings, Earnings Beats, News
aTyr Pharma (NASDAQ:LIFE) reported quarterly losses of $(0.23) per share which beat the analyst consensus estimate of $(0.24) by 4.17 percent. This is a 20.69 percent increase over losses of $(0.29) per share from the same period last year. The company reported quarterly sales of $235.00 thousand which beat the analyst consensus estimate of $20.00 thousand by 1.08K percent.